ClinicalTrials.Veeva

Menu

Impact of Hospital Pharmacist Intervention on Medication Management in Dialysis Patients (IPhaDia)

V

Vichy Hospital Center

Status

Not yet enrolling

Conditions

Health Literacy Level
Kidney Disease, Chronic
Renal Dialysis

Treatments

Behavioral: Pharmacist intervention

Study type

Interventional

Funder types

Other

Identifiers

NCT06692231
CHV-2024-10

Details and patient eligibility

About

The goal of this clinical trial is to learn if an intervention of a hospital pharmacist could help, dialysis patients managed his treatment. In a first time, the health literacy level will be assed.

The main questions it aims to answer are:

What is the impact of the clinical pharmacist intervention on the understanding level and management level of his treatment by the patient? Does the intervention of the pharmacist has an effect on the biologicals parameters of the patient? Researchers will compare a group with a pharmacist intervention VS a group without pharmacist intervention for dialysis patients.

Enrollment

70 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient over 18 years of age
  • On dialysis (peritoneal dialysis, hemodialysis) for at least 3 months
  • Prescription for at least 5 daily medications
  • Patient who has not received any pharmaceutical consultation from a hospital pharmacist as part of his or her treatment for chronic renal failure.

Exclusion criteria

  • Patient does not speak and/or understand French
  • Patient's cognitive state does not permit an interview
  • Patient not autonomous in managing his or her daily medication (e.g.: patient in nursing home)
  • Patient refusal

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

70 participants in 2 patient groups

Controle Arm
No Intervention group
Description:
Control arm: will have no specific intervention
Intervention Arm
Experimental group
Description:
Intervention arm: Patient will have an interview with a clinical pharmacist to explain the role of each medication. The pharmacist will also explain the best moment to take each medication.
Treatment:
Behavioral: Pharmacist intervention

Trial contacts and locations

1

Loading...

Central trial contact

Aurélien PIRAUD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems